Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Internal Medicine

Prolaris is a prostate-specific antigen (PSA) genetic test that analyzes cancer cells of patients diagnosed with prostate cancer. The test determines the aggressiveness of the cancer, helping physicians identify low- and medium-risk patients. This...
Sequencing an individual patient’s genome is no longer cost prohibitive. Physicians can use this information to develop custom-tailored treatments that have shown efficacy in other patients with similar genetic characteristics. This is the basis of...
There have been many advancements in chemotherapy and immunotherapy treatments for various cancers over the past decade, but the 5-year relative survival rate for glioblastoma patients is still around 10%. Since glioblastoma is a rare condition, an RO-1...